The National Institutes of Standards and Technology proposed new guidance late last week that seeks to expand conditions under which federal government agencies can apply march-in rights, a provision of the 1980 Bayh-Doyle Act, to include consideration for pricing of pharmaceutical drugs.
A year ago, South Dakota voters initiated and overwhelmingly approved Amendment D, expanding Medicaid coverage to more than 50,000 residents who did not previously qualify.
A year ago, South Dakota voters initiated and overwhelmingly approved Amendment D, expanding Medicaid coverage to more than 50,000 residents who did not previously qualify.
Those folks fell into the coverage gap, with incomes above the state’s Medicaid eligibility level but also just barely above the poverty line, meaning they could not afford marketplace plans. What Medicaid expansion meant for people in the gap, in a practical sense, is that they no longer were forced to forego basic medical care to cover rent, food, childcare, or other basic needs.
Today, the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to key Congressional leaders urging them to advance legislation that comprehensively addresses the nation’s ongoing drug shortage crisis ahead of a Senate Finance Committee hearing Tuesday.
For cancer patients and survivors caught in the coverage gap, we know access to health care means comprehensive coverage for cessation and other resources to help Mississippians with limited incomes successfully quit smoking, but it also means access to screening, medications, and life-saving treatment.
A new national poll reveals that patients are counting on lawmakers to solve the medical debt crisis. U.S. adults say it is past time for federal and state policymakers to act.
A coalition of the country’s leading public health advocacy organizations filed a friend-of-the-court brief in Texas v. Mayorkas in the United States District Court for the Southern District of Texas to urge the court to uphold the Biden administration’s 2022 “public charge” policy. Amici include American Cancer Society; American Cancer Society Cancer Action Network (ACS CAN); American Lung Association; CancerCare; Epilepsy Foundation; Hemophilia Federation of America; Leukemia & Lymphoma Society; Muscular Dystrophy Association; National Multiple Sclerosis Society; National Patient Advocate Foundation; and Susan G. Komen.
The nation’s drug shortage crisis continues to affect cancer patients and survivors with 1 in every 10 (10%) reporting impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (45%). The data is part of a new survey by the American Cancer Society Cancer Action Network (ACS CAN).
Today, the American Cancer Society Cancer Action Network (ACS CAN) was overjoyed to see the legislature pass oral chemotherapy fairness legislation. ACS CAN looks forward to seeing the Governor sign this critical legislation into law soon and celebrating our volunteers’ hard work to get this legislation over the finish line.
The American Cancer Society Cancer Action Network (ACS CAN) was thrilled to see the Senate Health Policy Committee pass oral chemotherapy fairness legislation unanimously today.